• Profile
Close

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?

European Journal of Obstetrics & Gynecology and Reproductive Biology Jan 12, 2018

Matarazzo MG, et al. - The authors aimed at evaluating the urodynamic effects of ultralow-dose estriol vaginal gel formulation to treat women with Genitourinary Syndrome of Menopause and Overactive Bladder Syndrome. Findings suggested a local ultra-low dose concentration of estriol as efficient for improving both subjective symptoms and urodynamic parameters of storage function not affecting voiding function in women with vaginal atrophy and Overactive Bladder Syndrome.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay